These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 1689316

  • 1. Augmented desensitization to epidermal growth factor (EGF) immediate actions: a novel mechanism for altered EGF growth response in mutant A431 cells.
    Karasik A, Reddy SS, Pepinsky RB, Brock T, Kahn CR.
    J Cell Physiol; 1990 Feb; 142(2):231-5. PubMed ID: 1689316
    [Abstract] [Full Text] [Related]

  • 2. Comparison of protein phosphorylations in variant A431 cells with different growth responses to epidermal growth factor.
    Buss JE, Chouvet C, Gill GN.
    J Cell Physiol; 1984 Jun; 119(3):296-306. PubMed ID: 6202705
    [Abstract] [Full Text] [Related]

  • 3. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG, Carlin S, Workman P.
    Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism.
    Donato NJ, Rosenblum MG, Steck PA.
    Cell Growth Differ; 1992 May; 3(5):259-68. PubMed ID: 1378752
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor beta modulation of the epidermal growth factor Ca2+ signal and c-Fos oncoprotein levels in A431 human epidermoid carcinoma cells.
    Elliget KA, Phelps PC, Smith MW.
    Cell Growth Differ; 1996 Apr; 7(4):461-8. PubMed ID: 9052987
    [Abstract] [Full Text] [Related]

  • 6. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ, Ince C, Rosenblum MG, Gallick GE.
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [Abstract] [Full Text] [Related]

  • 7. Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibody.
    Sunada H, Yu P, Peacock JS, Mendelsohn J.
    J Cell Physiol; 1990 Feb; 142(2):284-92. PubMed ID: 1689318
    [Abstract] [Full Text] [Related]

  • 8. Importance of tyrosine phosphatases in the effects of cell-cell contact and microenvironments on EGF-stimulated tyrosine phosphorylation.
    Mansbridge JN, Knüchel R, Knapp AM, Sutherland RM.
    J Cell Physiol; 1992 Jun; 151(3):433-42. PubMed ID: 1284249
    [Abstract] [Full Text] [Related]

  • 9. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
    Gardner DP, Shimizu N.
    J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
    [Abstract] [Full Text] [Related]

  • 10. Expression of functional epidermal growth factor receptors in a human hematopoietic cell line.
    Oval J, Hershberg R, Gansbacher B, Gilboa E, Schlessinger J, Taetle R.
    Cancer Res; 1991 Jan 01; 51(1):150-6. PubMed ID: 1703031
    [Abstract] [Full Text] [Related]

  • 11. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z, Masui H, Altas I, Mendelsohn J.
    Cancer Res; 1993 Sep 15; 53(18):4322-8. PubMed ID: 8364927
    [Abstract] [Full Text] [Related]

  • 12. Role of epidermal growth factor-stimulated protein kinase in control of proliferation of A431 cells.
    Gill GN, Buss JE, Lazar CS, Lifshitz A, Cooper JA.
    J Cell Biochem; 1982 Sep 15; 19(3):249-57. PubMed ID: 6296169
    [Abstract] [Full Text] [Related]

  • 13. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
    Castagnola J, MacLeod C, Sunada H, Mendelsohn J, Taetle R.
    J Cell Physiol; 1987 Sep 15; 132(3):492-500. PubMed ID: 3498729
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of epidermal growth factor-induced phosphorylation by trifluoperazine.
    Ross AH, Damsky C, Phillips PD, Hwang F, Vance P.
    J Cell Physiol; 1985 Sep 15; 124(3):499-506. PubMed ID: 2413056
    [Abstract] [Full Text] [Related]

  • 15. Analysis of morphology and receptor metabolism in clonal variant A431 cells with differing growth responses to epidermal growth factor.
    Lifshitz A, Lazar CS, Buss JE, Gill GN.
    J Cell Physiol; 1983 Jun 15; 115(3):235-42. PubMed ID: 6304117
    [Abstract] [Full Text] [Related]

  • 16. Epidermal growth factor-dependent phosphorylation of lipocortin.
    Pepinsky RB, Sinclair LK.
    Nature; 1983 Jun 15; 321(6065):81-4. PubMed ID: 3010133
    [Abstract] [Full Text] [Related]

  • 17. Ligand activation of overexpressed epidermal growth factor receptor results in colony dissociation and disturbed E-cadherin function in HSC-1 human cutaneous squamous carcinoma cells.
    Fujii K, Furukawa F, Matsuyoshi N.
    Exp Cell Res; 1996 Feb 25; 223(1):50-62. PubMed ID: 8635495
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.
    Gulli LF, Palmer KC, Chen YQ, Reddy KB.
    Cell Growth Differ; 1996 Feb 25; 7(2):173-8. PubMed ID: 8822200
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.